Replies to post #230 on Ritter Pharmaceuticals Inc (RTTR)

[Klinsmann]

Same here, but won´t sell a single shares in the high 0,70´s. Looks like FDA approval for an unique lactose intolerance treatment is possible this year...

RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease that affects over one billion people worldwide.

The Phase 2b/3 program is underway. Results expected in 2017.

http://www.ritterpharmaceuticals.com/product-platform/rpg28